Castle Biosciences (CSTL) Intangibles (2018 - 2022)

Castle Biosciences has disclosed Intangibles across 3 years of filings, most recently posting $87.3 million for Q1 2022.

• Intangibles for Q1 2022 came in at $87.3 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2022 was $87.3 million (changed N/A YoY), and the FY2021 annual result was $88.9 million, changed N/A from the prior year.
• Intangibles came in at $87.3 million for Q1 2022 at Castle Biosciences, down from $88.9 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $88.9 million in Q4 2021 to a low of $4000.0 in Q4 2018.
• The 3-year median for Intangibles is $32.8 million (2021), against an average of $48.2 million.